Tenet Healthcare Corp. revenue by year
Over the 10 fiscal years shown, revenue went from $19.62B (year ended Dec 31, 2016) to $21.31B (year ended Dec 31, 2025), a compound annual growth rate of 0.9%. The fastest growth was +10.5% in the year ended Dec 31, 2021; the weakest year was −4.5% (year ended Dec 31, 2020).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $21.31B | +3.1% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 17, 2026 |
| Dec 31, 2024 | $20.68B | +0.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 17, 2026 |
| Dec 31, 2023 | $20.56B | +7.2% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 17, 2026 |
| Dec 31, 2022 | $19.17B | −1.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 18, 2025 |
| Dec 31, 2021 | $19.48B | +10.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 16, 2024 |
| Dec 31, 2020 | $17.64B | −4.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 21, 2023 |
| Dec 31, 2019 | $18.48B | +0.9% | Revenues | 10-K filed Feb 24, 2020 |
| Dec 31, 2018 | $18.31B | −4.5% | Revenues | 10-K filed Feb 24, 2020 |
| Dec 31, 2017 | $19.18B | −2.3% | Revenues | 10-K filed Feb 24, 2020 |
| Dec 31, 2016 | $19.62B | — | Revenues | 10-K filed Feb 25, 2019 |
Tenet Healthcare Corp. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $5.63B | +6.5% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2026 | $5.63B | +6.8% | 10-Q filed Jul 29, 2026 |
| 3 months ended Mar 31, 2026 | $5.37B | +2.8% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2025 | $5.29B | +3.2% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2025 | $5.27B | +3.2% | 10-Q filed Jul 29, 2026 |
| 3 months ended Mar 31, 2025 | $5.22B | −2.7% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2024 | $5.13B | +1.2% | 10-Q filed Oct 28, 2025 |
| 3 months ended Jun 30, 2024 | $5.11B | +0.5% | 10-Q filed Jul 30, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 70318 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.